Interactions on record — worth a quick check against your medications. Based on 3 of 10 ingredients. Check your meds →
Dietary supplement

Target gb-X 5 Billion CFU Ingredients & Drug Interactions

by Klaire Labs

Target gb-X 5 Billion CFU label
See full label image
Other (e.g. Tea Bag) Category: Other Combinations
Most serious interaction: Moderate
Clinical methodology reviewed by · Updated Sep 16, 2026 · Label data from the NIH DSLD
What is this page for?

First and foremost: checking Target gb-X 5 Billion CFU against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.

Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy

The interaction bottom line Most serious interaction: Moderate

Target gb-X 5 Billion CFU is a dietary supplement by Klaire Labs with 10 active ingredients. Its ingredients are commonly taken for preventing or treating low potassium (hypokalemia), supporting healthy blood pressure, muscle cramps.Based on those ingredients, 244 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Bifidobacterium bifidum W23, Lactobacillus acidophilus W37, Potassium. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

Jump to a section

Check Your Meds Against Target gb-X 5 Billion CFU by Klaire Labs

Ask about any prescription or over-the-counter medication and we check it for interactions with Target gb-X 5 Billion CFU by Klaire Labs — and tell you which ingredient is responsible.

Pharmacist-reviewed data Checks every ingredient Answer in seconds
Prefer a human? Send your question to our licensed pharmacists — free, answered by email within 24 hours.

HelloPharmacist Scorecard of Target gb-X 5 Billion CFU by Klaire Labs

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

Generated from HelloPharmacist’s pharmacist-curated databases and editorial rules · Last generated Jul 11, 2026

What’s inside

Low disclosure
Ingredient Transparency · database check
Low

Most active ingredients don't disclose an individual amount — you can't tell how much of each you're getting.

Why this rating?
  • The label discloses an exact amount for 1 of its 10 active ingredients.
  • “Ecologic Barrier Probiotic Blend” is a proprietary blend — the label gives one combined amount (2 Gram(s)) without saying how much of each component you get.

Target gb-X contains 10 active ingredients: the mineral potassium plus nine live probiotic bacterial strains, including Bifidobacterium bifidum, Lactobacillus acidophilus, and several others that support digestive and immune health. The inactive ingredients are maize starch, maltodextrin, inulin, polydextrose, protein, magnesium sulfate, and manganese sulfate.

Does it work?

Moderate evidence
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Moderate

Some clinical evidence supports this product's ingredients for its stated purpose, but it isn't conclusive.

Why this rating?
  • The label markets this product for: Gut brain axis support probiotic supplement.
  • We looked for evidence on: Antibiotic-associated diarrhea, Irritable bowel syndrome (IBS), Lactose intolerance, Constipation, Inflammatory bowel disease (IBD), Ulcerative colitis — and 4 related terms.
  • The strongest evidence on file: Lactobacillus Acidophilus is rated "Possibly Effective" for Antibiotic-associated diarrhea (Natural Medicines).
  • Also on file: Lactobacillus Acidophilus is rated "Possibly Effective" for Bacterial vaginosis, Irritable bowel syndrome (IBS).
  • Also on file: Bifidobacterium Bifidum is rated "Possibly Effective" for Irritable bowel syndrome (IBS).

The probiotics in this blend have been studied for a few specific uses. Bifidobacterium bifidum and Lactobacillus acidophilus are both possibly effective for irritable bowel syndrome (IBS).

Lactobacillus acidophilus is also possibly effective for Helicobacter pylori infection, antibiotic-associated diarrhea, and bacterial vaginosis. For other conditions like hay fever, anxiety, and Alzheimer disease, the evidence isn't established.

Lactobacillus acidophilus appears ineffective for atopic disease. We don't hold effectiveness data for the other probiotic strains in this product.

The evidence, ingredient by ingredient Potassium Bifidobacterium Bifidum Lactobacillus Acidophilus

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 3 of the 3 matched ingredients.
  • Pregnancy & breastfeeding safety ratings cover 3 of 3.
  • General safety write-ups exist for 3 of 3.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Potassium from food is fine, but supplements carry real risks — especially for people with kidney disease. The safety data advises using potassium supplements only under medical guidance during pregnancy and to check with your doctor before using them while breastfeeding.

The probiotic strains are generally well tolerated in healthy people. Bifidobacterium bifidum and Lactobacillus acidophilus may cause bloating, flatulence, or mild gastrointestinal discomfort, though these are uncommon.

People with weakened immune systems should be cautious with probiotics. Because the evidence on these strains is limited, check with your doctor or pharmacist before you start.

Side effects, ingredient by ingredient Potassium Bifidobacterium Bifidum Lactobacillus Acidophilus

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 3 of the 3 matched ingredients can interact with medications — Lactobacillus Acidophilus, Potassium, Bifidobacterium Bifidum.
  • The most serious interaction on file is rated Moderate.
  • For scale: 244 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

If you take blood pressure medications — especially ACE inhibitors, ARBs, or potassium-sparing diuretics — check with your pharmacist before you start; potassium levels can climb to dangerous heights. Also separate antibiotic drugs from this product by several hours, since antibiotics may kill the live bacteria and make the probiotic less effective.

No interactions are documented for the other probiotic strains we could check.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFormula with limited ingredient disclosure with some supporting evidence for its stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.

This product is a probiotic blend aimed at people with digestive concerns like IBS, but it also contains potassium at levels that need medical oversight. If you take blood pressure medications (especially ACE inhibitors or ARBs) or potassium-sparing diuretics, or if you have kidney disease, talk to your pharmacist before trying it.

If you're on antibiotics, separate them from this product by a few hours. Always run it past your pharmacist or doctor first.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 3 of 10 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Dec 21, 2024.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Target gb-X 5 Billion CFU, straight from the product label.

Brand Klaire Labs
Barcode (UPC) 790616310081
Net contents 30 Sachet(s)
Market status On market
Date entered into DSLD Dec 21, 2024
DSLD ID 322459
Product type Other Combinations
Supplement form Other (e.g. Tea Bag)
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Children 4 or More Years of Age, Adult (18 - 50 Years), Gluten Free, Dairy Free, Children more than 1 but less than 4
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Target gb-X 5 Billion CFU by Klaire Labs, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
1 Sachet(s)
Maximum serving Sizes:
1 Sachet(s)
Servings per container
30
UPC/BARCODE
790616310081
IngredientAmount% DV
Calories10 Calorie(s)--
Total Carbohydrates2 Gram(s)1%
Potassium30 mg1%
Bifidobacterium bifidum W230 NP--
Lactobacillus acidophilus W370 NP--
Lactobacillus brevis W630 NP--
Lactobacillus casei W560 NP--
Lactobacillus salivarius W240 NP--
Ecologic Barrier Probiotic Blend2 Gram(s)--
Lactococcus lactis lactis W580 NP--
Bifidobacterium animalis lactis W520 NP--
Lactococcus lactis lactis W190 NP--
Bifidobacterium animalis lactis W510 NP--

Other ingredients: Maize Starch, Maltodextrin, Inulin, Polydextrose, Protein, Magnesium Sulfate, Manganese Sulfate

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Formulation

Gut brain axis Pure Formulas

Free of the following common allergens: milk/casein, eggs, fish, shellfish, tree nuts, peanuts, wheat, gluten, soybeans, and yeast.

Produced under a strict quality management system in compliance with Good Manufacturing Practices (GMPs) and third-party quality certifications. Made in the Netherlands with global ingredients.

The gut microbiota supports many normal functions including deterrence of undesirable bacteria through nutrient competition, adhesion inhibition, and the luminal pH environment. Healthful bacteria also support intestinal barrier function and influence innate and adaptive immune responses. One of the most intriguing aspects of a healthy microbiota is the cognitive influence via the gut-brain axis, which includes functions such as neurotransmitter and cytokine production along with the beneficial activity of bacterial metabolites such as butyrate. Target gb-X strains were specifically selected to support the gut-brain axis and have demonstrated a positive effect on healthy mood. 2. Cryan and Dinan. Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012;13:701-12. 3. Steenbergen et al. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun 2015;48:258-64.

Non GMO

FDA Statement of Identity

Probiotic Supplement

Formula

Ecologic Inside

Target gb-X contains Ecologic BARRIER, a proprietary multispecies probiotic. The bacterial strains of Ecologic BARRIER have been selected for their capacity to strengthen intestinal barrier integrity and support healthy immune response. 1. van Hemert and Ormel. Influence of the multispecies Probiotic Ecologic BARRIER on parameters of intestinal barrier function. Food Nutr Sci 2014; 5:1739-64.

Precautions

Caution: When antiobiotics are used, wait 2-3 hours before using this product.

If you are pregnant, nursing, have a medical condition, or taking prescription drugs, consult your healthcare professional before using this product.

Keep out of reach of children.

Suggested/Recommended/Usage/Directions

Suggested Use: Dissolve the content of 1 sachet daily in water (3-4 oz.), preferably lukewarm, and stir before consumption. Take on an empty stomach in the morning, before bed, or as directed by a healthcare professional. Suitable for children from the age of 1 year.

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Storage

Shelf stable. Store in a cool, dry place (59 degrees F - 85 degrees F) away from direct light.

General Statements

SFI

Is this label outdated? Report a formula or label change and our pharmacy team will review it.

See for yourself

Target gb-X 5 Billion CFU by Klaire Labs label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

Target gb-X 5 Billion CFU label

Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.

View the full label (PDF)
What’s inside

The Ingredients in Target gb-X 5 Billion CFU by Klaire Labs

These are the 10 active ingredients this product is made of. Select any to open its full monograph.

Serving size1 Sachet(s) Dosage formOther (e.g. Tea Bag) Servings per container30 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

Potassium

Interacts with
62 drugs
30 mg per serving Form: Potassium Chloride

Potassium is an essential mineral your body needs for nerve signals, muscle function, and a steady heartbeat, and most people get enough from a balanc...

Potassium monograph & interactions

Ecologic Barrier Probiotic Blend

2 Gram(s) per serving
  • › Bifidobacterium bifidum W23
  • › Lactobacillus acidophilus W37
  • › Lactobacillus brevis W63
  • › Lactobacillus casei W56
  • › Lactobacillus salivarius W24
  • › Lactococcus lactis lactis W58
  • › Bifidobacterium animalis lactis W52
  • › Lactococcus lactis lactis W19
  • › Bifidobacterium animalis lactis W51

Other (inactive) ingredients: Maize Starch, Maltodextrin, Inulin, Polydextrose, Protein, Magnesium Sulfate, Manganese Sulfate. These complete the product’s ingredient list but are not active constituents.

Interaction report

Target gb-X 5 Billion CFU by Klaire Labs Drug Interactions

Want to check YOUR meds against Target gb-X 5 Billion CFU?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

 Go to the checker
244Drugs
244 Moderate

Ingredients driving the most interactions

Bifidobacterium bifidum W23 182
Lactobacillus acidophilus W37 182
Potassium 62

Individual Drug Interactions

The ingredients in Target gb-X 5 Billion CFU interact with 244 drugs. Click any drug to see the details.

3 of the 10 ingredients in Target gb-X 5 Billion CFU interact with drugs. Each result below shows which ingredient is responsible. Bifidobacterium bifidum W23 Lactobacillus acidophilus W37 Potassium

Each ingredient & the kinds of drugs it affects

For each ingredient in Target gb-X 5 Billion CFU with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.

Bifidobacterium bifidum W231 drug type · 182 drugs

Antibiotic Drugs

Theoretically, taking Bifidobacterium. bifidum with antibiotic drugs might decrease the effectiveness of B. bifidum.
Since B. bifidum preparations usually contain live and active organisms, simultaneously taking antibiotics might kill a significant number of the organisms. Tell patients to separate administration of antibiotics and B. bifidum preparations by at least 2 hours.

Likelihood Probable Evidence D
Bifidobacterium bifidum W23 full monograph & interactions

Lactobacillus acidophilus W371 drug type · 182 drugs

Antibiotic Drugs

Theoretically, taking Lactobacillus acidophilus with antibiotic drugs might decrease the effectiveness of L. acidophilus.
L. acidophilus preparations usually contain live and active organisms. Therefore, simultaneously taking antibiotics might kill a significant number of the organisms. Tell patients to separate administration of antibiotics and L. acidophilus preparations by at least two hours.

Likelihood Probable Evidence D
Lactobacillus acidophilus W37 full monograph & interactions

Potassium3 drug types · 62 drugs

Ace Inhibitors (Aceis)

Using ACEIs with high doses of potassium increases the risk of hyperkalemia.
ACEIs block the actions of the renin-angiotensin-aldosterone system and reduce potassium excretion. Concomitant use of these drugs with potassium supplements increases the risk of hyperkalemia. However, concomitant use of these drugs with moderate dietary potassium intake (about 3775-5200 mg daily) does not increase serum potassium levels.

Likelihood Likely Evidence C
Angiotensin Receptor Blockers (Arbs)

Using ARBs with high doses of potassium increases the risk of hyperkalemia.
ARBs block the actions of the renin-angiotensin-aldosterone system and reduce potassium excretion. Concomitant use of these drugs with potassium supplements increases the risk of hyperkalemia. However, concomitant use of these drugs with moderate dietary potassium intake (about 3775-5200 mg daily) does not increase serum potassium levels.

Likelihood Likely Evidence C
Potassium-Sparing Diuretics

Concomitant use increases the risk of hyperkalemia.
Using potassium-sparing diuretics with potassium supplements increases the risk of hyperkalemia.

Likelihood Likely Evidence C
Potassium full monograph & interactions
The maker

Brand information

Manufacturer and brand details for Target gb-X 5 Billion CFU, from the product label.

Klaire Labs

See all Klaire Labs products
Name
SFI USA
City
Reno
State
NV
ZipCode
89521
Web Address
Klaire.com
Pharmacist Counseling Corner

Target gb-X 5 Billion CFU by Klaire Labs: Common Questions

Does Target gb-X 5 Billion CFU by Klaire Labs interact with any medications?
Yes. Based on its ingredients, Target gb-X 5 Billion CFU has a known interaction with 244 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Target gb-X 5 Billion CFU contains 10 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Will this probiotic work if I'm on an antibiotic?
Taking it at the same time might not, because antibiotics kill the live bacteria in the product. The facts suggest spacing them out by a few hours, but ask your pharmacist for the best timing with your specific antibiotic.
What side effects might I see from the probiotics?
Bloating and flatulence are the most common complaints with probiotics in general. Gastrointestinal discomfort, abdominal pain, and diarrhea have been reported in some trials, but they're uncommon. One case of vomiting and fever was reported in a child, though it's unclear if the probiotics caused it.
Is this safe to take while pregnant?
The potassium in this product is rated likely safe in pregnancy, but supplements should only be used under medical guidance. Pregnancy/lactation data on the specific probiotic strains in this blend isn't on file, so talk with your doctor before starting.
Can I take this if I have kidney disease?
Talk to your doctor first. Potassium supplements can build up to dangerous levels in people with kidney problems, since your kidneys control how much potassium your body keeps.
Does this product contain fillers?
Yes — it includes maize starch, maltodextrin, inulin, polydextrose, protein, magnesium sulfate, and manganese sulfate as inactive ingredients.
Will this help my allergies or hay fever?
The evidence for Bifidobacterium bifidum and allergic rhinitis (hay fever) isn't established — there's not enough reliable data to say whether it works for that.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Target gb-X 5 Billion CFU is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Target gb-X 5 Billion CFU label
Go deeper

The Full Monographs Behind Target gb-X 5 Billion CFU’s Ingredients

Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.

Herb & supplement monograph

Potassium

Interacts with 62 drugs

Potassium is an essential mineral your body needs for nerve signals, muscle function, and a steady heartbeat, and most people get enough from a balanced diet rich in fruits and vegetables. P...

Read the full Potassium monograph → Herb & supplement monograph

Bifidobacterium Bifidum

Interacts with 182 drugs

Bifidobacterium bifidum is a 'friendly' bacteria (probiotic) that naturally lives in the human gut and is taken to support digestion and gut balance. Some evidence suggests probiotics may he...

Read the full Bifidobacterium Bifidum monograph → Herb & supplement monograph

Lactobacillus Acidophilus

Interacts with 182 drugs

Lactobacillus acidophilus is a 'friendly' bacterium used as a probiotic to support gut and vaginal health. It is generally well tolerated in healthy people, and there is reasonable evidence...

Read the full Lactobacillus Acidophilus monograph →
Sources

Sources & How We Checked

Target gb-X 5 Billion CFU's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 34 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Potassium 12 references
  1. McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
  2. Gennaro A. Remington: The Science and Practice of Pharmacy. 19th ed. Lippincott: Williams & Wilkins, 1996.
  3. Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997;277:1624-32. PubMed
  4. Phillips, C. O., Kashani, A., Ko, D. K., Francis, G., and Krumholz, H. M. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from ra DOI
  5. Altieri, P. I., Herrero, C., Suero, R., and Ortiz, A. Bleeding duodenal ulcer in a patient taking slow-releasing potassium tablets. Bol.Asoc.Med P.R. 1977;69(8):276.
  6. Raf, L. E. Enteric-coated potassium chloride tablets and ulcer of the small intestine. Acta Chir Scand Suppl 1967;(374):1-87.
  7. Potassium chloride oral solution [package insert]. Allentown, PA: Lehigh Valley Technologies, Inc.; 2014.
  8. Potassium chloride injection [package insert]. Lake Forest, IL: Hospira Inc.; 2009.
  9. Patel RB, Tannenbaum S, Viana-Tejedor A, et al. Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36. Eur Heart J Acute Cardiovasc Care 2017 Feb;6(1):1 PubMed
  10. Malta D, Arcand J, Ravindran A, Floras V, Allard JP, Newton GE. Adequate intake of potassium does not cause hyperkalemia in hypertensive individuals taking medications that antagonize the renin angiotensin aldosterone system. Am J Clin Nutr 2016 Oct;104(4 PubMed
  11. Keskin M, Kaya A, Tatlisu MA, et al. The effect of serum potassium level on in-hospital and long-term mortality in ST elevation myocardial infarction. Int J cardiol. 2016 Oct 15;221:505-10.
  12. Stallings VA, Harrison M, Oria M; Committee to Review the Dietary Reference Intakes for Sodium and Potassium, Food and Nutrition Board, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine. Washington (DC): National Acad

See these in context on the Potassium monograph →

Bifidobacterium Bifidum 7 references
  1. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
  2. Xiao JZ, Takahashi S, Odamaki T, et al. Antibiotic susceptibility of bifidobacterial strains distributed in the Japanese market. Biosci Biotechnol Biochem. 2010;74(2):336-42. PubMed
  3. Rerksuppaphol S, Rerksuppaphol L. Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatr Int. 2012;54(5):682-7. PubMed
  4. Karamali M, Dadkhah F, Sadrkhanlou M, et al. Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Metab 2016;42(4):234-41. PubMed
  5. Badehnoosh B, Karamali M, Zarrati M, et al. The effects of probiotic supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes. J Matern Fetal Neonatal Med. 2018 May;31(9):1128-1136.
  6. Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med. 2019;27(2):175-178.
  7. Esaiassen E, Hjerde E, Cavanagh JP, Simonsen GS, Klingenberg C; Norwegian Study Group on Invasive Bifidobacterial Infections. Bifidobacterium bacteremia: Clinical characteristics and a genomic approach to assess pathogenicity. J Clin Microbiol. 2017;55(7) PubMed

See these in context on the Bifidobacterium Bifidum monograph →

Lactobacillus Acidophilus 15 references
  1. Pierce A. The American Pharmaceutical Association Practical Guide to Natural Medicines. New York: The Stonesong Press, 1999:19.
  2. Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial. Scand J Gastroenterol 2013;48(10):1127-35 PubMed
  3. Chatterjee S, Kar P, Das T, Ray S, Gangulyt S, Rajendiran C, Mitra M. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated
  4. Shavakhi A, Tabesh E, Yaghoutkar A, Hashemi H, Tabesh F, Khodadoostan M,Minakari M, Shavakhi S, Gholamrezaei A. The effects of multistrain probiotic compound on bismuth-containing quadruple therapy for Helicobacter pylori infection: a randomized placebo-c
  5. Karamali M, Dadkhah F, Sadrkhanlou M, et al. Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Metab 2016;42(4):234-41. PubMed
  6. Badehnoosh B, Karamali M, Zarrati M, et al. The effects of probiotic supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes. J Matern Fetal Neonatal Med. 2018 May;31(9):1128-1136.
  7. Kumar S, Kumar R, Rohilla L, Jacob N, Yadav J, Sachdeva N. A high potency multi-strain probiotic improves glycemic control in children with new-onset type 1 diabetes mellitus: A randomized, double-blind, and placebo-controlled pilot study. Pediatr Diabete
  8. Shahriari A, Karimi E, Shahriari M, Aslani N, Khooshideh M, Arab A. The effect of probiotic supplementation on the risk of gestational diabetes mellitus among high-risk pregnant women: A parallel double-blind, randomized, placebo-controlled clinical trial PubMed
  9. Xiao SD, Zhang DZ, Lu H, et al. Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea. Adv Ther. 2003;20(5):253-60.
  10. Rossi F, Amadoro C, Gasperi M, Colavita G. Lactobacilli infection case reports in the last three years and safety implications. Nutrients. 2022;14(6):1178. PubMed
  11. Ozer M, Goksu SY, Shahverdiani A, Mustafa M. Lactobacillus acidophilus-induced endocarditis and associated splenic abscess. Case Rep Infect Dis 2020;2020:1382709.
  12. Sadrin S, Sennoune S, Gout B, et al. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial. Dig Liver Dis 2020;52(5):534-540. PubMed
  13. Stoffer JN, Slingsby TJ, Giuliari GP. Lactobacillus acidophilus endophthalmitis after intravitreal bevacizumab injection requiring intraocular lens explantation. Can J Ophthalmol 2022;57(1):e21-e22. PubMed
  14. Cukovic-Cavka S, Likic R, Francetic I, Rustemovic N, Opacic M, Vucelic B. Lactobacillus acidophilus as a cause of liver abscess in a NOD2/CARD15-positive patient with Crohn's disease. Digestion 2006;73(2-3):107-10.
  15. Hui J, Ren Y, Wang Y, Han Q. Lactobacillus acidophilus endophthalmitis postcataract operation: A case report with a literature review. Ocul Immunol Inflamm 2023.

See these in context on the Lactobacillus Acidophilus monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring
Supplement interaction checker › Check any supplement or product against your medications Drug–drug interactions › Check two or more of your medications against each other Browse medications A–Z › Every drug we've checked against herbs & supplements NDC & pricing lookup › Find a drug’s NDCs, packaging and costs Ask a pharmacist › Free, personal answer from our licensed team